title: Stochastic model for interhuman spread of monkeypox.
abstract: With the eradication of smallpox, systematic routine vaccination with vaccinia has ceased and an increasing proportion of the human population in tropical rain forest areas of central and western Africa lacks vaccinia-derived immunity to monkeypox virus. This raises the question of the ability of monkeypox virus to establish and maintain itself in an unvaccinated population through continuous man-to-man transmission. A computerized stochastic model of Monte Carlo type was constructed to assess this potential risk. Simulated series were repeated 100 times to obtain distributions of predicted outcomes for decreasing levels of vaccination coverage (70 per cent, 50 per cent, and 0 per cent). The results revealed a substantial increase in new secondary cases in the total absence of vaccinia-induced immunity. Nevertheless, none of the simulated series did lead to an "explosive" epidemic. The model clearly indicated diminishing numbers of cases in successive generations and eventual cessation of transmission. Therefore, it appears highly improbable that the virus could maintain itself permanently in communities by interhuman transmission. After the eradication of smallpox, human monkeypox constitutes the most important orthopoxvirus infection in man, but analysis of information collected up to this time suggests that it does not represent currently a serious public health problem or a challenge to the achieved eradication of smallpox.
authors.affiliation: Smallpox Eradication Unit, World Health Organization, Geneva, Switzerland.
authors.forename: Z
authors.initials: Z
authors.lastname: Jezek
authors.forename: B
authors.initials: B
authors.lastname: Grab
authors.forename: H
authors.initials: H
authors.lastname: Dixon
mesh_terms: D000293:Adolescent; D000818:Animals; D002648:Child; D003198:Computer Simulation; D015023:Democratic Republic of the Congo; D006801:Humans; D008962:Models, Theoretical; D008993:Monkeypox virus; D009010:Monte Carlo Method; D011213:Poxviridae Infections / Q000453:epidemiology / Q000635:transmission*; D012306:Risk; D012899:Smallpox / Q000517:prevention & control; D012900:Smallpox Vaccine / Q000276:immunology*; D014611:Vaccination; D015047:Zoonoses / Q000635:transmission
chemical_list: D012900:Smallpox Vaccine